BioCatalyst

Zibotentan/Dapagliflozin, Dapagliflozin — catalyst calendar

1 verified catalyst event(s) referencing Zibotentan/Dapagliflozin, Dapagliflozin, each linked to its official source. Verified as of 2026-10-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-18
in 4mo
ESTIMATED
 READOUT
Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflo
Phase 3 · Chronic Kidney Disease With High Proteinuria
 AZN ASTRAZENECA PLC Zibotentan/Dapagliflozin, Dapagliflozin ClinicalTrials.gov ↗
✓ Source-checked 2026-10-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.